当前位置: 首页 > 期刊 > 《世界华人消化杂志》 > 2007年第16期
编号:11495561
慢性HBV感染的免疫治疗
http://www.100md.com 2007年6月8日 于贤杰, 王贵强
慢性HBV感染;免疫治疗;树突状细胞;调节性T细胞;CD8+T细胞;治疗性疫苗,于贤杰,王贵强,通讯作者:,ImmunotherapyforchronichepatitisBvirusinfections,Xian-JieYu,Gui-QiangWang,Cor
第4页
第1页

    参见附件(548KB,6页)。

     于贤杰, 北京大学第一医院病毒研究室 北京市 100034

    王贵强, 北京大学第一医院感染疾病科 北京市 100034

    通讯作者: 王贵强, 100034, 北京市, 北京大学第一医院感染疾病科. wanggq@hotmail.com

    电话: 010-66551122-2370

    收稿日期: 2007-03-30 接受日期: 2007-04-13

    Immunotherapy for chronic hepatitis B virus infectionsXian-Jie Yu, Gui-Qiang Wang

    

    Xian-Jie Yu,
Laboratory of Virology, Peking University First Hospital, Beijing 100034, China

    Gui-Qiang Wang, Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China

    Correspondence to: Gui-Qiang Wang, Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China. wanggq@hotmail.com

    Received: 2007-03-30 Accepted: 2007-04-13

    Abstract

    The immune system functions to control and clear virus infections. Viral persistence has been closely associated with dysfunctional specific immunity, especially cellular immunity. Current antiviral therapies have been disappointing. Immunotherapies with strategies to boost or restore the virus-specific immune response of patients with chronic hepatitis B virus infection have been proposed for curing persistent infections, and are attracting increasing attention. This review summarizes recent advances in the field of immunology and the immunotherapy of chronic HBV infections, including dendritic, regulatory T and CD8+ T cells, and discusses therapeutic vaccines.

    Key Words: Chronic hepatitis B virus infection; Immunotherapy; Dendritic cell; Regulatory T cell; CD8+ T cell; Therapeutic vaccine

    Yu XJ, Wang GQ. Immunotherapy for chronic hepatitis B virus infections. Shijie Huaren Xiaohua Zazhi 2007;15(16):1835-1840

    摘要

    目前现有的抗病毒药物对慢性HBV感染的疗效不甚满意. HBV感染的控制和清除有赖于机体的免疫系统, 其感染慢性化与机体特异性免疫, 尤其是细胞免疫功能低下密切相关. 旨在通过增强或恢复机体抗HBV免疫功能以控制和清除HBV感染的免疫治疗是被人们寄予厚望的一种治疗策略, 备受关注. 本文将从树突状细胞、调节性T细胞、CD8+ T细胞、治疗性疫苗等几个方面对近几年慢性HBV感染的免疫学和免疫治疗研究进展进行综述.

    关键词: 慢性HBV感染; 免疫治疗; 树突状细胞; 调节性T 细胞; CD8+ T细胞; 治疗性疫苗 ......

您现在查看是摘要介绍页,详见PDF附件(548KB,6页)